Aigen Investment Management, LP Immuno Gen, Inc. Transaction History

Aigen Investment Management, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 02, 2022	SELL	$3.15 - $5.76 $54,850 - $100,298	-17,413 Closed	0 $0
Q1 2022 May 05, 2022	SELL	$4.26 - $7.48 $11,932 - $20,951	-2,801 Reduced 13.86%	17,413 $83,000
Q4 2021 Feb 11, 2022	BUY	$4.75 - $7.5 $96,016 - $151,605	20,214 New	20,214 $141,000
Q2 2021 Aug 10, 2021	SELL	$5.79 - $8.6 $132,683 - $197,077	-22,916 Closed	0 $0
Q1 2021 May 11, 2021	BUY	$6.5 - $10.53 $148,954 - $241,305	22,916 New	22,916 $186,000
Q1 2020 May 08, 2020	SELL	$2.12 - $6.8 $173 - $557	-82 Closed	0 $0
Q4 2019 Feb 04, 2020	BUY	$2.25 - $5.8 $184 - $475	82 New	82 $0

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

Stay updated on Aigen Investment Management, LP with notifications on news.